Form 8-K - Current report:
SEC Accession No. 0001193125-24-282502
Filing Date
2024-12-20
Accepted
2024-12-20 08:10:30
Documents
21
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d815097d8k.htm   iXBRL 8-K 43904
2 EX-4.1 d815097dex41.htm EX-4.1 226139
3 EX-10.1 d815097dex101.htm EX-10.1 673135
4 EX-10.2 d815097dex102.htm EX-10.2 290131
5 EX-10.3 d815097dex103.htm EX-10.3 38233
6 EX-10.4 d815097dex104.htm EX-10.4 333308
7 EX-10.5 d815097dex105.htm EX-10.5 81123
8 EX-99.1 d815097dex991.htm EX-99.1 12746
12 GRAPHIC g815097dsp221.jpg GRAPHIC 9760
  Complete submission text file 0001193125-24-282502.txt   2112190

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA iobt-20241219.xsd EX-101.SCH 2857
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20241219_lab.xml EX-101.LAB 17911
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20241219_pre.xml EX-101.PRE 11239
23 EXTRACTED XBRL INSTANCE DOCUMENT d815097d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

IRS No.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 241565187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)